130 related articles for article (PubMed ID: 18353085)
1. A pilot study of fluorescence diagnosis of basal cell carcinoma using a digital flash light-based imaging system.
Gambichler T; Moussa G; Altmeyer P
Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):67-71. PubMed ID: 18353085
[TBL] [Abstract][Full Text] [Related]
2. Preoperative assessment of basal cell carcinoma using conventional fluorescence diagnosis.
Neus S; Gambichler T; Bechara FG; Wöhl S; Lehmann P
Arch Dermatol Res; 2009 Apr; 301(4):289-94. PubMed ID: 18979108
[TBL] [Abstract][Full Text] [Related]
3. Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery.
Stenquist B; Ericson MB; Strandeberg C; Mölne L; Rosén A; Larkö O; Wennberg AM
Br J Dermatol; 2006 Feb; 154(2):305-9. PubMed ID: 16433801
[TBL] [Abstract][Full Text] [Related]
4. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T
Urology; 2007 Apr; 69(4):675-9. PubMed ID: 17445650
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence detection and diagnosis of non-melanoma skin cancer at an early stage.
de Leeuw J; van der Beek N; Neugebauer WD; Bjerring P; Neumann HA
Lasers Surg Med; 2009 Feb; 41(2):96-103. PubMed ID: 19226578
[TBL] [Abstract][Full Text] [Related]
6. Does surface preparation alter ALA uptake in superficial non-melanoma skin cancer in vivo?
Moseley H; Brancaleon L; Lesar AE; Ferguson J; Ibbotson SH
Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):72-5. PubMed ID: 18353086
[TBL] [Abstract][Full Text] [Related]
7. No clinical benefit of preoperative fluorescence diagnosis of basal cell carcinoma localized in the H-zone of the face.
Wetzig T; Kendler M; Maschke J; Paasch U; Simon JC
Br J Dermatol; 2010 Jun; 162(6):1370-6. PubMed ID: 20302577
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence--remission sensoring of skin tumours: preliminary results.
Wollina U; Nelskamp C; Scheibe A; Fassler D; Schmidt WD
Skin Res Technol; 2007 Nov; 13(4):463-71. PubMed ID: 17908200
[TBL] [Abstract][Full Text] [Related]
9. Can basal cell carcinoma lateral border be determined by fluorescence diagnosis?: Verification by Mohs micrographic surgery.
El Hoshy K; Bosseila M; El Sharkawy D; Sobhi R
Photodiagnosis Photodyn Ther; 2016 Jun; 14():4-8. PubMed ID: 26790611
[TBL] [Abstract][Full Text] [Related]
10. Methyl-ALA-induced fluorescence in photodynamic diagnosis of basal cell carcinoma prior to Mohs micrographic surgery.
Redondo P; Marquina M; Pretel M; Aguado L; Iglesias ME
Arch Dermatol; 2008 Jan; 144(1):115-7. PubMed ID: 18209183
[No Abstract] [Full Text] [Related]
11. Spectrophotometric intracutaneous analysis in the diagnosis of basal cell carcinoma: a pilot study.
Tehrani H; Walls J; Cotton S; Sassoon E; Hall P
Int J Dermatol; 2007 Apr; 46(4):371-5. PubMed ID: 17442075
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence imaging for the demarcation of basal cell carcinoma tumor borders.
Alkalay R; Alcalay J; Maly A; Ingber A; Fritsch C; Ruzicka T; Enk CD
J Drugs Dermatol; 2008 Nov; 7(11):1033-7. PubMed ID: 19110733
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence lifetime imaging distinguishes basal cell carcinoma from surrounding uninvolved skin.
Galletly NP; McGinty J; Dunsby C; Teixeira F; Requejo-Isidro J; Munro I; Elson DS; Neil MA; Chu AC; French PM; Stamp GW
Br J Dermatol; 2008 Jul; 159(1):152-61. PubMed ID: 18460029
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence hysteroscopy using 5-aminolevulinic: a descriptive study.
Wyss P; Degen A; Caduff R; Hornung R; Haller U; Fehr M
Lasers Surg Med; 2003; 33(3):209-12. PubMed ID: 12949952
[TBL] [Abstract][Full Text] [Related]
15. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
[TBL] [Abstract][Full Text] [Related]
16. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
[TBL] [Abstract][Full Text] [Related]
17. Multiphoton excitation fluorescence microscopy of 5-aminolevulinic acid induced fluorescence in experimental gliomas.
Kantelhardt SR; Diddens H; Leppert J; Rohde V; Hüttmann G; Giese A
Lasers Surg Med; 2008 Apr; 40(4):273-81. PubMed ID: 18412229
[TBL] [Abstract][Full Text] [Related]
18. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
19. [Intraoperative photodynamic diagnosis for spinal ependymoma using 5-aminolevulinic acid: technical note].
Arai T; Tani S; Isoshima A; Nagashima H; Joki T; Takahashi-Fujigasaki J; Abe T
No Shinkei Geka; 2006 Aug; 34(8):811-7. PubMed ID: 16910494
[TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomography for the characterization of basal cell carcinoma in vivo: a pilot study.
Olmedo JM; Warschaw KE; Schmitt JM; Swanson DL
J Am Acad Dermatol; 2006 Sep; 55(3):408-12. PubMed ID: 16908344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]